Related Experiment Video

Updated: Dec 22, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians

Markus S Anker1,2,3,4, Claire Bouleti5, Theodoros Christodoulides6

  • 1Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.

ESC Heart Failure
|May 1, 2020
PubMed

Insights

The Heart failure specialists of Tomorrow (HoT) group connects early-career professionals in cardiology. This European Society of Cardiology initiative fosters collaboration and offers career development opportunities for its growing international membership.

Area of Science:

  • Cardiology
  • Medical Research
  • Professional Networks

Background:

  • The Heart failure specialists of Tomorrow (HoT) group was established in 2014.
  • It operates under the Heart Failure Association of the European Society of Cardiology.
  • The group has rapidly expanded to 925 members, comprising diverse healthcare professions.

Purpose of the Study:

  • To foster a collaborative network for young professionals in heart failure.
  • To provide career development and networking opportunities.
  • To facilitate international collaborations among early-career researchers and clinicians.

Main Methods:

  • Membership recruitment and community building.
  • Organizing sessions and events at the Heart Failure and World Congress on Acute Heart Failure.
  • Facilitating access to grants, moderated poster sessions, and career-focused events.

Main Results:

  • Rapid growth to 925 members since 2014.
  • Established a cohesive international community.
  • Provides tangible benefits including travel grants and networking opportunities.

Conclusions:

  • The HoT group is a significant and expanding resource for early-career professionals in heart failure.
  • It successfully promotes collaboration and professional growth within the European Society of Cardiology.
  • The initiative enhances opportunities for young researchers and clinicians in the field of heart failure.

Keywords:
Heart failureHeart failure specialists of tomorrowNetwork

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.1K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.3K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
585
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
608
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
368
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
233